clodronic acid has been researched along with Non-alcoholic Fatty Liver Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasuzawa, N; Kabashima, M; Nomura, M; Tatsushima, K; Tokubuchi, R | 1 |
| Bader, JE; Carson, MS; Enos, RT; McGuinness, OP; Murphy, EA; Robinson, CM; Sougiannis, AT; Velázquez, KT | 1 |
| Akiyoshi, K; Aoe, S; Fukaishi, T; Hamaguchi, M; Itoh, M; Kanai, S; Kato, H; Komohara, Y; Konuma, K; Marumoto, Y; Ogawa, Y; Sakaida, I; Sakugawa, H; Suganami, T; Takeya, M; Terai, S | 1 |
| Cani, PD; Horsmans, Y; Lanthier, N; Leclercq, IA; Molendi-Coste, O; van Rooijen, N | 1 |
| Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Tsai, TH; Yang, YY | 1 |
1 review(s) available for clodronic acid and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
[VNUT Is a Therapeutic Target for Type 2 Diabetes and NASH].
Topics: Adenosine Triphosphate; Animals; Clodronic Acid; Diabetes Mellitus, Type 2; Drug Discovery; Humans; Insulin Resistance; Insulin Secretion; Mice, Knockout; Molecular Targeted Therapy; Non-alcoholic Fatty Liver Disease; Nucleotide Transport Proteins; Secretory Vesicles | 2021 |
4 other study(ies) available for clodronic acid and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Repeated clodronate-liposome treatment results in neutrophilia and is not effective in limiting obesity-linked metabolic impairments.
Topics: Adipose Tissue; Animals; Body Weight; Clodronic Acid; Cytokines; Diet, Fat-Restricted; Diet, High-Fat; Energy Intake; Insulin Resistance; Lipid Metabolism; Liposomes; Liver; Macrophages; Male; Mice; Neutrophils; Non-alcoholic Fatty Liver Disease; Obesity; RNA, Messenger | 2019 |
Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans.
Topics: Animals; Chronic Disease; Clodronic Acid; Fatty Liver; Female; Hepatitis, Viral, Human; Humans; Inflammation; Lipid Metabolism; Liposomes; Liver; Liver Cirrhosis; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Non-alcoholic Fatty Liver Disease; Phenotype; Receptor, Melanocortin, Type 4 | 2013 |
Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet.
Topics: Adipose Tissue; Adiposity; Animals; Clodronic Acid; Diet, High-Fat; Fatty Liver; Inflammation; Insulin Resistance; Kupffer Cells; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity | 2011 |
Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis.
Topics: Analysis of Variance; Animals; Arachidonic Acid; Benzofurans; Choline; Clodronic Acid; Diet, High-Fat; DNA Primers; Fatty Acids, Unsaturated; Fatty Liver; Gadolinium; Hemodynamics; Hypertension, Portal; Insulin Resistance; Kupffer Cells; Leptin; Methionine; Methoxamine; Microcirculation; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Receptors, Thromboxane A2, Prostaglandin H2; RNA, Messenger; Sulfonylurea Compounds; Thiobarbituric Acid Reactive Substances; Thromboxane A2 | 2012 |